Disgraced Clone Expert Barred from Work
By The West Australian,
The West Australian
| 07. 31. 2008
South Korea will not allow disgraced cloning expert Hang Woo-suk to resume human stem cell research, it has been reported.
Hwang's request was turned down by the country's national committee on bioethics, Yonhap news agency reported on Thursday.
The health ministry declined to comment on the report but said it would brief the media on Friday.
"He engaged in unethical and wrongful acts in the past and the committee decided to reject it," a source who took part in the committee meeting was quoted by Yonhap as saying.
"One committee member strongly argued that it would bring shame on the whole country," the source said.
Hwang's claims that he created the first human stem cells through cloning were ruled to be bogus, and he is banned from research using human eggs.
But the scientist is now engaged in animal cloning at the Sooam Biotech Research Foundation, which in December asked for the green light to begin a new embryonic stem cell research project using aborted human eggs.
Still on trial for fraud, embezzlement, ethical breaches and other charges, Hwang has...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...